FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for diagnosing the activity of the combined infection in children with acute respiratory infections. In children with idiopathic leukopenia and febrile convulsions in blood, presence, activity and serotype of herpes virus of type 6, its quantitative characteristics are detected, immunoglobulins IgM, IgG of class are detected, avidity of immunoglobulins IgG of class is determined. If HHV-6 DNA is present in an amount of not less than 104 copies/ml, genotype A, IgM, IgG antibodies with avidity index less than 40 % diagnose active infectious herpes-virus process.
EFFECT: invention provides higher accuracy of diagnosing ensured by complex sequential virological diagnosis with assessment of activity of HHV-6, its genotype and its involvement in development and severity of disease.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINATION OF INDICATIONS FOR ANTIHERPETIC THERAPY IN CASE OF HHV-6 INFECTION IN CHILDREN WITH ACUTE RESPIRATORY DISEASES | 2017 |
|
RU2641609C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF CNS ORGANIC LESIONS IN CHILDREN WITH HERPES VIRAL INFECTIONS | 2019 |
|
RU2729988C1 |
METHOD FOR PREDICTING HUMAN TYPE 6 HERPES VIRUS INFECTION IN CHILDREN | 2018 |
|
RU2695323C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF LATENT AND ACTIVE FORMS OF HHV-6 INFECTION IN CHILDREN | 2023 |
|
RU2817089C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF HERPES VIRUS MIXED INFECTION | 2020 |
|
RU2739854C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF CNS ORGANIC LESIONS IN CHILDREN DURING THE ACUTE PERIOD | 2017 |
|
RU2648215C1 |
METHOD FOR ASSESSMENT OF ACTIVITY OF INFECTION CAUSED BY HERPES TYPE 4, 5 AND 6 IN CHILDREN | 2016 |
|
RU2639593C1 |
METHOD OF DETERMINING AVIDITY OF IMMUNOGLOBULIN G TO HERPES VIRUS TYPE 6 | 2015 |
|
RU2596794C1 |
METHOD FOR DIAGNOSING CHRONIC LYMPHOPROLIFERATIVE DISEASES OF THE NASOPHARYNX IN CHILDREN ASSOCIATED WITH THE COMBINED EFFECT OF ATMOSPHERIC CHEMICAL FACTORS AND PERSISTENT HERPES VIRUS INFECTION | 2022 |
|
RU2782143C1 |
METHOD FOR EVALUATION OF EFFICIENCY OF TYPE 6 HUMAN HERPES VIRUS INFECTION THERAPY IN CHILDREN | 2016 |
|
RU2646472C1 |
Authors
Dates
2019-11-14—Published
2019-05-31—Filed